Hercules Capital Gelecekteki Büyüme

Future kriter kontrolleri 2/6

Hercules Capital kazanç ve gelirin sırasıyla yıllık 4.1% ve 4% oranında artacağı tahmin edilmektedir. EPS'nin yıllık 0.6% oranında büyümesi beklenmektedir. Özkaynak kârlılığının 3 yıl içinde 16% olacağı tahmin edilmektedir.

Anahtar bilgiler

4.1%

Kazanç büyüme oranı

0.6%

EPS büyüme oranı

Capital Markets kazanç büyümesi	18.7%
Gelir büyüme oranı	4.0%
Gelecekteki özkaynak getirisi	16.0%
Analist kapsamı	Good
Son güncelleme	05 Nov 2024

Gelecekteki son büyüme güncellemeleri

Güncelleme yok

Recent updates

Kazanç ve Gelir Büyüme Tahminleri

LSE:0J4M - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (USD Millions )
Tarih	Gelir	Kazançlar	Serbest Nakit Akışı	Faaliyetlerden Nakit	Avg. Analist Sayısı
12/31/2026	537	330	N/A	N/A	5
12/31/2025	530	334	N/A	N/A	8
12/31/2024	502	294	N/A	N/A	8
9/30/2024	494	318	41	42	N/A
6/30/2024	486	278	-167	-166	N/A
3/31/2024	477	331	-93	-92	N/A
12/31/2023	461	334	67	68	N/A
9/30/2023	438	277	-128	-128	N/A
6/30/2023	406	302	-66	-65	N/A
3/31/2023	362	197	-317	-317	N/A
12/31/2022	322	100	-425	-425	N/A
9/30/2022	294	42	-260	-260	N/A
6/30/2022	280	12	-166	-166	N/A
3/31/2022	277	105	-10	-10	N/A
12/31/2021	281	172	129	129	N/A
9/30/2021	284	319	260	260	N/A
6/30/2021	284	339	208	208	N/A
3/31/2021	282	318	182	182	N/A
12/31/2020	287	226	208	208	N/A
9/30/2020	283	120	-38	-38	N/A
6/30/2020	281	96	-2	-2	N/A
3/31/2020	283	83	-124	-124	N/A
12/31/2019	268	173	-241	-241	N/A
9/30/2019	254	111	-361	-360	N/A
6/30/2019	238	128	-407	-407	N/A
3/31/2019	218	132	-454	-454	N/A
12/31/2018	208	76	-249	-249	N/A
9/30/2018	201	111	-211	-210	N/A
6/30/2018	194	109	N/A	-180	N/A
3/31/2018	193	90	N/A	33	N/A
12/31/2017	191	78	N/A	-18	N/A
9/30/2017	188	74	N/A	-3	N/A
6/30/2017	187	72	N/A	11	N/A
3/31/2017	182	48	N/A	-44	N/A
12/31/2016	175	67	N/A	-138	N/A
9/30/2016	167	67	N/A	-94	N/A
6/30/2016	169	41	N/A	-16	N/A
3/31/2016	164	34	N/A	-83	N/A
12/31/2015	157	41	N/A	-114	N/A
9/30/2015	155	48	N/A	-71	N/A
6/30/2015	145	59	N/A	-160	N/A
3/31/2015	140	69	N/A	-176	N/A
12/31/2014	144	70	N/A	-27	N/A
9/30/2014	140	74	N/A	65	N/A
6/30/2014	144	96	N/A	150	N/A
3/31/2014	145	104	N/A	187	N/A
12/31/2013	140	98	N/A	104	N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: 0J4M 'nin tahmini kazanç büyümesi (yıllık 4.1% ) tasarruf oranının ( 2.1% ) üzerindedir.

Kazançlar ve Piyasa: 0J4M şirketinin kazançlarının (yıllık 4.1% ) UK pazarından (yıllık 14.6% ) daha yavaş büyümesi öngörülüyor.

Yüksek Büyüme Kazançları: 0J4M şirketinin kazançlarının artması bekleniyor, ancak önemli ölçüde.

Gelir ve Pazar: 0J4M şirketinin gelirinin (yıllık 4% ) UK pazarından (yıllık 3.6% ) daha hızlı büyümesi öngörülüyor.

Yüksek Büyüme Geliri: 0J4M şirketinin gelirinin (yıllık 4% ) yıllık 20% oranından daha yavaş büyümesi öngörülüyor.

Hisse Başına Kazanç Büyüme Tahminleri

Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: 0J4M 'nin Özsermaye Getirisi'nin 3 yıl içinde düşük olması tahmin ediliyor ( 16 %).

Hercules Capital Gelecekteki Büyüme

Future kriter kontrolleri 2/6

Anahtar bilgiler

Gelecekteki son büyüme güncellemeleri

Recent updates

Third quarter 2024 earnings released: EPS: US$0.42 (vs US$0.19 in 3Q 2023)

Second quarter dividend of US$0.48 announced

Hercules Capital, Inc. Declares Cash Distribution for the Third Quarter 2024, Payable on November 20, 2024

Hercules Capital, Inc. to Report Q3, 2024 Results on Oct 30, 2024

Hercules Capital, Inc. to Report Q3, 2024 Results on Oct 30, 2024

Hologic, Inc. (NasdaqGS:HOLX) agreed to acquire Gynesonics, Inc. for $350 million.

KARL STORZ Endoscopy-America, Inc. completed the acquisition of Asensus Surgical, Inc. (NYSEAM:ASXC).

KARL STORZ Endoscopy-America, Inc. completed the acquisition of Asensus Surgical, Inc. (NYSEAM:ASXC).

Second quarter 2024 earnings released: EPS: US$0.26 (vs US$0.66 in 2Q 2023)

First quarter dividend of US$0.48 announced

Hercules Capital, Inc. Declares Cash Distribution for the Second Quarter 2024, Payable on August 20, 2024

Hercules Capital, Inc. to Report Q2, 2024 Results on Aug 01, 2024

Haveli Investments Software Fund I, L.P., a fund managed by Haveli Investment Management LLC completed the acquisition of ZeroFox Holdings, Inc. (NasdaqGM : ZFOX) from Monarch Alternative Capital LP and Others.

First quarter dividend of US$0.48 announced

First quarter 2024 earnings released: EPS: US$0.58 (vs US$0.69 in 1Q 2023)

Hercules Capital, Inc. Declares First Quarter Cash Dividend, Payable on May 14, 2024

Hercules Capital, Inc., Annual General Meeting, Jun 20, 2024

Hercules Capital, Inc. to Report Q1, 2024 Results on May 02, 2024

KARL STORZ SE & Co. KG entered into an agreement to acquire Asensus Surgical, Inc. (NYSEAM:ASXC) for $100 million.

Upcoming dividend of US$0.48 per share

Full year 2023 earnings released: EPS: US$2.34 (vs US$0.80 in FY 2022)

Hercules Capital, Inc. Declares Cash Distribution for the Fourth Quarter 2023, Dividend Payable on March 6, 2024

Haveli Investments Software Fund I, L.P., a fund managed by Haveli Investment Management LLC entered into an Agreement and Plan of Merger to acquire ZeroFox Holdings, Inc. (NasdaqGM : ZFOX) from Monarch Alternative Capital LP and Others for approximately $150 million.

Hercules Capital, Inc. to Report Q4, 2023 Results on Feb 15, 2024

Upcoming dividend of US$0.48 per share at 12% yield

Third quarter 2023 earnings released: EPS: US$0.19 (vs US$0.41 in 3Q 2022)

Hercules Capital, Inc. Declares Total Cash Distribution the Third Quarter 2023, Payable on November 22, 2023

Hercules Capital, Inc. to Report Q3, 2023 Results on Nov 02, 2023

New major risk - Revenue and earnings growth

Hercules Capital Appoints Nikos Theodosopoulos an Independent Member of its Board of Directors and to Serve on Audit Committee

Upcoming dividend of US$0.48 per share at 11% yield

Hercules Capital, Inc. has completed a Follow-on Equity Offering.

New major risk - Revenue and earnings growth

Second quarter 2023 earnings released: EPS: US$0.67 (vs US$0.088 loss in 2Q 2022)

Hercules Capital Declares Cash Distribution for the Second Quarter 2023, Payable August 25, 2023

Hercules Capital, Inc. to Report Q2, 2023 Results on Aug 03, 2023

Hercules Capital, Inc. to Report Q2, 2023 Results on Aug 03, 2023

Independent Director recently bought US$98k worth of stock

First quarter 2023 earnings released: EPS: US$0.70 (vs US$0.033 loss in 1Q 2022)

Investor sentiment deteriorates as stock falls 18%

Upcoming dividend of US$0.47 per share at 13% yield

Full year 2022 earnings released: EPS: US$0.80 (vs US$1.50 in FY 2021)

Hercules Capital Increases Its Quarterly Cash Distribution for the Fourth Quarter of 2022, Payable on March 9, 2023

Hercules Capital, Inc. to Report Q4, 2022 Results on Feb 16, 2023

Hercules Capital, Inc. Announces Resignation of Brad Koenig as Member of the Board

Third quarter 2022 earnings released: EPS: US$0.42 (vs US$0.20 in 3Q 2021)

Upcoming dividend of US$0.51 per share

Sumitovant Biopharma Ltd. signed an agreement to acquire a 47.83% stake in Myovant Sciences Ltd for $1.2 billion.

Amgen Inc. (NasdaqGS:AMGN) completed the acquisition of ChemoCentryx, Inc. (NasdaqGS:CCXI) from a group of shareholders.

Hercules Capital, Inc. to Report Q3, 2022 Results on Nov 02, 2022

Hercules Capital, Inc. Declares Cash Distribution for the Third Quarter of 2022, Payable on November 17, 2022

Sumitovant Biopharma Ltd. entered into a non-binding proposal to acquire Myovant Sciences Ltd. (NYSE:MYOV) for $1.2 billion.

Upcoming dividend of US$0.50 per share

Second quarter 2022 earnings released: US$0.083 loss per share (vs US$0.71 profit in 2Q 2021)

Hercules Capital, Inc. Increases Quarterly Cash Distribution for the Second Quarter of 2022, Payable on August 16, 2022

Hercules Capital, Inc. to Report Q2, 2022 Results on Jul 28, 2022

Hercules Capital, Inc. Appoints Deanne Aguirre to its Board of Directors

First quarter 2022 earnings released: US$0.028 loss per share (vs US$0.56 profit in 1Q 2021)

Hercules Capital, Inc. Announces Cash Distribution for the First Quarter of 2022, Payable on May 24, 2022

Hercules Capital, Inc., Annual General Meeting, Jun 23, 2022

Hercules Capital, Inc. to Report Q1, 2022 Results on May 05, 2022

Upcoming dividend of US$0.48 per share

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Hercules Capital Declares Cash Distribution for the Fourth Quarter of 2021, Payable on March 16, 2022

Hercules Capital, Inc. to Report Q4, 2021 Results on Feb 22, 2022

Hercules Capital, Inc. Announces Executive Changes

High number of new directors

Upcoming dividend of US$0.40 per share

Third quarter 2021 earnings released: EPS US$0.20 (vs US$0.38 in 3Q 2020)

Chief Compliance Officer, General Counsel & Secretary Melanie Grace has left the company

Chief Compliance Officer, General Counsel & Secretary Melanie Grace has left the company

Upcoming dividend of US$0.39 per share

Second quarter 2021 earnings released: EPS US$0.71 (vs US$0.55 in 2Q 2020)

Independent Director Carol Foster has left the company

Thoma Bravo, LLC reached an agreement to acquire Greenphire, Inc. from The Riverside Company, Hercules Capital, Inc. (NYSE:HTGC) and Ares Capital Management LLC.